Champions Oncology, Inc. (CSBR)
NASDAQ·Healthcare·Biotechnology
$4.79
+0.63%
Mkt Cap $81.23M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+150.5%
Consensus $12.00 vs current $4.79
NASDAQ·Healthcare·Biotechnology
$4.79
+0.63%
Mkt Cap $81.23M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+150.5%
Consensus $12.00 vs current $4.79